18Sep
Breakthrough Newsflash!
I recieved this email today and thought I would share it with everyone-please have a read!!
Dear supporter,
We are getting in touch with you today to share news of an important research discovery from our scientists at the Breakthrough Breast Cancer Research Centre at the Institute of Cancer Research (ICR).
We are delighted to report that Breakthrough scientists have discovered that a new cancer treatment could be used with about a third of breast cancer patients. They could also be used for a significant proportion of prostate, colon, and intestinal cancers. This is particularly exciting because the drugs, called PARP inhibitors, work in a targeted way, which means fewer side effects for patients.
Here is the summary of the findings from Professor Alan Ashworth, Director of the Breakthrough Breast Cancer Research Centre at the ICR, who led on this research:
“I think this new class of drugs represents a real breakthrough in cancer treatment.
“A clinical trial has shown this year that these drugs could be used to treat rare forms of cancer that run in families. Importantly, this drug, given in tablet form, had very few side effects, unlike chemotherapy.
“Our scientists have now shown that PARP inhibitors could be used to treat thousands of patients. These include common cancers such as breast, skin, womb, prostrate or intestinal cancer.
“We still need to await the results of clinical trials but we are optimistic these drugs have a big future. This shows the real benefits of applying cutting edge science to cancer treatment.”
These results have made front page news and I have attached just some of today’s articles which I hope you will enjoy reading.
On behalf of all of us at Breakthrough, I would like to take this opportunity to thank you for all your support; it is only with the invaluable help of supporters like you that we are able to continue saving lives and changing futures with our world-class research.
Many thanks and best wishes,
Nicola Clements
Read more on the topic at The Daily Express, The Sun and BBC News websites.
